EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Deletion of the mRNA endonuclease Regnase-1 promotes NK cell anti-tumor activity via OCT2-dependent transcription of Ifng

Xin Sun, Yasuharu Nagahama, Shailendra Kumar Singh, Yuuki Kozakai, Hiroshi Nabeshima, Kiyoharu Fukushima, Hiroki Tanaka, Daisuke Motooka, Eriko Fukui, Eric Vivier, Diego Diez, Shizuo Akira

Immunity · 2024-06 · 57 (6) · 1360-1377.e13

DOI: 10.1016/j.immuni.2024.05.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2024-06. Verfasst von Xin Sun und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Host Defense, WPI Immunology Frontier Research Center (WPI-IFReC), Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan; Quan…. Hauptthemen laut MEDLINE: Interferon-gamma, Killer Cells, Natural, Tumor Microenvironment. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Otsuka Pharmaceutical Co Ltd, Japan Science and Technology Agency, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Limited infiltration and activity of natural killer (NK) and T cells within the tumor microenvironment (TME) correlate with poor immunotherapy responses. Here, we examined the role of the endonuclease Regnase-1 on NK cell anti-tumor activity. NK cell-specific deletion of Regnase-1 (Reg1ΔNK) augmented cytolytic activity and interferon-gamma (IFN-γ) production in vitro and increased intra-tumoral accumulation of Reg1ΔNK-NK cells in vivo, reducing tumor growth dependent on IFN-γ. Transcriptional changes in Reg1ΔNK-NK cells included elevated IFN-γ expression, cytolytic effectors, and the chemokine receptor CXCR6. IFN-γ induced expression of the CXCR6 ligand CXCL16 on myeloid cells, promoting further recruitment of Reg1ΔNK-NK cells. Mechanistically, Regnase-1 deletion increased its targets, the transcriptional regulators OCT2 and IκBζ, following interleukin (IL)-12 and IL-18 stimulation, and the resulting OCT2-IκBζ-NF-κB complex induced Ifng transcription. Silencing Regnase-1 in human NK cells increased the expression of IFNG and POU2F2. Our findings highlight NK cell dysfunction in the TME and propose that targeting Regnase-1 could augment active NK cell persistence for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon-gammaKiller Cells, NaturalTumor MicroenvironmentAnimalsHumansMiceCell Line, TumorMice, Inbred C57BLMice, KnockoutNF-kappa BRibonucleasesTranscription, Genetic

Stichwörter der Autor:innen

CXCR6-CXCL16 axisIκBζNF-κBNK cellsOCT2Regnase-1anti-tumor immunitytranscriptional complextranscriptional regulation of Ifngtumor microenvironment

Substanzen

Interferon-gammaNF-kappa BRibonucleasesZc3h12a protein, mouse

Autor:innen und Institutionen

  • Laboratory of Host Defense, WPI Immunology Frontier Research Center (WPI-IFReC), Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan; Quantitative Immunology Unit, WPI-IFReC, Osaka University, 3-1 Yamada-oka,…
  • Laboratory of Host Defense, WPI Immunology Frontier Research Center (WPI-IFReC), Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan; Host Defense Laboratory, Immunology Unit, Department of Medical Innovation…
  • Laboratory of Host Defense, WPI Immunology Frontier Research Center (WPI-IFReC), Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan; Joint Research Chair of Innate Immunity for Drug Discovery, WPI-IFReC, Osa…
  • Laboratory of Host Defense, WPI Immunology Frontier Research Center (WPI-IFReC), Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan.
  • NGS Core Facility of the Genome Information Research Center, RIMD, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan.
  • Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.

Förderung

  • Otsuka Pharmaceutical Co Ltd
  • Japan Science and Technology Agency
  • Japan Agency for Medical Research and Development

Zitieren

APA

Sun, X., Nagahama, Y., Singh, S. K., Kozakai, Y., Nabeshima, H., Fukushima, K., Tanaka, H., Motooka, D., Fukui, E., Vivier, E., Diez, D., & Akira, S. (2024). Deletion of the mRNA endonuclease Regnase-1 promotes NK cell anti-tumor activity via OCT2-dependent transcription of Ifng. Immunity, 57(6), 1360-1377.e13. https://doi.org/10.1016/j.immuni.2024.05.006

Vancouver

Sun X, Nagahama Y, Singh SK, Kozakai Y, Nabeshima H, Fukushima K, et al. Deletion of the mRNA endonuclease Regnase-1 promotes NK cell anti-tumor activity via OCT2-dependent transcription of Ifng. Immunity. 2024;57(6):1360-1377.e13. doi:10.1016/j.immuni.2024.05.006

BibTeX
@article{Sun2024,
  author = {Sun, Xin and Nagahama, Yasuharu and Singh, Shailendra Kumar and Kozakai, Yuuki and Nabeshima, Hiroshi and Fukushima, Kiyoharu and Tanaka, Hiroki and Motooka, Daisuke and Fukui, Eriko and Vivier, Eric and Diez, Diego and Akira, Shizuo},
  title = {Deletion of the mRNA endonuclease Regnase-1 promotes NK cell anti-tumor activity via OCT2-dependent transcription of Ifng},
  journal = {Immunity},
  year = {2024},
  volume = {57},
  number = {6},
  pages = {1360--1377.e13},
  doi = {10.1016/j.immuni.2024.05.006}
}
Kostenlos starten →